| Torisel (temsirolimus) / Pfizer |
NCT00003712: CCI-779 in Treating Patients With Advanced Solid Tumors |
|
|
| Completed | 1 | 15 | US | temsirolimus | The University of Texas Health Science Center at San Antonio, National Cancer Institute (NCI), University of Texas, Wyeth is now a wholly owned subsidiary of Pfizer | Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 06/02 | 06/02 | | |
NCT00949026: Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis |
|
|
| Withdrawn | 1 | 0 | US | Temsirolimus (Torisel), Torisel | Emory University, Wyeth is now a wholly owned subsidiary of Pfizer | Brain Neoplasms | 05/10 | 05/10 | | |
NCT00784914: A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors |
|
|
| Completed | 1 | 12 | US | temsirolimus, pharmacological study, cytokine levels | City of Hope Medical Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors, Metastatic Cancer | 11/10 | 11/10 | | |
NCT01182883: A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors |
|
|
| Withdrawn | 1 | 0 | NA | IMC-A12, Temsirolimus | National Cancer Institute (NCI) | Brain Stem Neoplasms, Glioma, Pinealoma | 04/12 | 04/12 | | |
|
NCT01204450: Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma |
|
|
| Terminated | 1 | 7 | US | Temsirolimus, Torisel, Valproic Acid, VPA | UNC Lineberger Comprehensive Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific | 11/12 | 03/13 | | |
|
|
